Proprietary AI analyst is now available

ASBIS Valuation Multiples

Discover ASBIS's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Distribution Solutions Group, MCJ, HTC, Fenda Technology and more.

ASBIS Overview

About ASBIS

Asbisc Enterprises PLC engaged in the activity of the Group and the Company continues to be the trading and distribution of computer hardware and software. The company operates in four principal geographical areas - The former Soviet Union, Central Eastern Europe, Western Europe, and the Middle East and Africa.


Founded

1995

HQ

Cyprus

Employees

2.8K

Website

asbis.com

Financials (LTM)

Revenue: $4B
EBITDA: $139M

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

ASBIS Financials

ASBIS reported last 12-month revenue of $4B and EBITDA of $139M.

In the same LTM period, ASBIS generated $241M in gross profit, $139M in EBITDA, and $75M in net income.

Revenue (LTM)


ASBIS P&L

In the most recent fiscal year, ASBIS reported revenue of $4B and EBITDA of $117M.

ASBIS is profitable as of last fiscal year, with gross margin of 7%, EBITDA margin of 3%, and net margin of 2%.

See analyst estimates for ASBIS
LTMLast FY202320242025202620272028
Revenue$4B$4B$3B$3B$4B
Gross Profit$241M$279M$252M$240M$279M
Gross Margin6%7%8%8%7%
EBITDA$139M$117M$101M$97M$112M
EBITDA Margin3%3%3%3%3%
EBIT Margin3%3%4%3%3%
Net Profit$75M$61M$53M$54M$61M
Net Margin2%2%2%2%2%

Financial data powered by Morningstar, Inc.

ASBIS Stock Performance

ASBIS has current market cap of $1B, and enterprise value of $1B.

Market Cap Evolution


ASBIS's stock price is $23.00.

ASBIS share price increased by 14.2% in the last 30 days, and by 245.8% in the last year.

ASBIS has an EPS (earnings per share) of $1.09.

See more trading valuation data for ASBIS
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$1B-0.2%14.2%88.3%245.8%$1.09

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

ASBIS Valuation Multiples

ASBIS trades at 0.3x EV/Revenue multiple, and 9.8x EV/EBITDA.

See NTM and 2027E valuation multiples for ASBIS

EV / Revenue (LTM)


ASBIS Financial Valuation Multiples

As of June 5, 2026, ASBIS has market cap of $1B and EV of $1B.

ASBIS has a P/E ratio of 17.0x.

LTMLast FY202320242025202620272028
EV/Revenue0.3x0.4x0.4x0.5x0.4x
EV/EBITDA9.8x11.7x13.5x14.0x12.1x
EV/EBIT10.6x12.3x12.1x14.5x12.3x
EV/Gross Profit5.6x4.9x5.4x5.7x4.9x
P/E17.0x21.0x24.1x23.4x21.0x
EV/FCF16.6x10.1x49.2x174.1x10.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified ASBIS Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

ASBIS Margins & Growth Rates

ASBIS grew revenue by 23% and EBITDA by 45% in the last fiscal year.

In the most recent fiscal year, ASBIS reported gross margin of 7%, EBITDA margin of 3%, and net margin of 2%.

See estimated margins and future growth rates for ASBIS

ASBIS Margins

Last FY202420252026202720282029
Gross Margin7%8%7%6%
EBITDA Margin3%3%3%4%
EBIT Margin3%3%3%3%
Net Margin2%2%2%2%
FCF Margin3%0%3%1%

ASBIS Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth23%(2%)28%23%
Gross Profit Growth2%(5%)16%2%
EBITDA Growth45%(3%)15%51%
EBIT Growth42%(16%)18%42%
Net Profit Growth61%3%11%61%
FCF Growth(53%)(72%)1618%(53%)

Data powered by FactSet, Inc. and Morningstar, Inc.

ASBIS Operational KPIs

ASBIS's revenue per employee in the last FY averaged $1.4M, while opex per employee averaged $0.1M for the same period.

ASBIS's Rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

ASBIS's Rule of X is 60% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for ASBIS
LTMLast FY202320242025202620272028
Rule of 4021%26%---
Bessemer Rule of X48%60%---
Revenue per Employee-$1.4M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue3%3%3%3%3%
G&A Expenses to Revenue2%2%2%2%2%
Opex to Revenue-4%5%5%4%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Distribution Solutions Group1.0x1.0x11.8x11.7x
MCJ0.8x0.7x7.8x-
HTC11.3x7.1x3.7x(16.1x)
Fenda Technology3.5x-61.4x-
Aamal Company2.7x2.8x10.3x11.8x
Guangzhou Pearl River13.7x-(29.1x)-
Global Industrial0.9x0.9x11.5x11.8x
Sun Corp.17.2x18.7x10.2x-

This data is available for Pro users. Sign up to see all ASBIS competitors and their valuation data.

Start Free Trial

Acquisitions by ASBIS

ASBIS has acquired 2 companies to date.

Last acquisition by ASBIS was on October 1st 2025. ASBIS acquired CPT Praha for $600K (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by ASBIS

CPT Praha
Avectis
Description
CPT Praha is a Prague-based distributor of consumer electronics and professional audio equipment. The company supplies brands such as Bose, JBL, and Yamaha to retailers and installers across the Czech Republic. Operating from warehouses in the Prague metropolitan area, CPT Praha stocks amplifiers, speakers, headphones, and home theater systems, supporting both residential and commercial AV projects with delivery services nationwide.
Avectis is a Belarus-based system integrator specializing in control automation, security systems, and essential services for industrial facilities and infrastructure. Headquartered in Minsk, the company designs and implements SCADA, fire safety, and access control solutions for manufacturing plants, power stations, and transportation hubs across Eastern Europe.
HQ CountryCzech RepublicBelarus
HQ City
Prague
Minsk
Deal Date1 Oct 202515 Jul 2019
Valuation$600K$574M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all ASBIS acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by ASBIS

ASBIS has invested in 2 companies to date.

Latest investment by ASBIS was on November 9th 2022. ASBIS invested in ProMed BioSciences in their $800K Strategic investment round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by ASBIS

ProMed BioSciences
EMBIO Diagnostics
Description
ProMed BioSciences is a supplier of highly purified research and medical-grade collagen derived from animal tissues. The Macclesfield-headquartered company manufactures products under GMP conditions for clinical trials cosmetics and regenerative medicine applications meeting specifications for tissue engineering and wound care.
EMBIO Diagnostics is a Nicosia-based deep-tech firm developing sensor technologies for monitoring air, water, and food quality. Its B.EL.D portable analyzer delivers results in three minutes for allergens and contaminants via Bluetooth connectivity. The airbeld system monitors indoor pollutants and integrates with building management systems for automated reports. Operating in Europe and the Middle East, EMBIO participates in events like Gitex Global to advance IoT and AI-driven diagnostics.
HQ CountryCyprusCyprus
HQ City
Limassol
Nicosia
Deal Date9 Nov 202223 Dec 2021
RoundStrategic investmentSeed
Raised$800K$1M
InvestorsASBISASBIS; Kinisis Ventures
Valuation$5Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all ASBIS investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About ASBIS

When was ASBIS founded?ASBIS was founded in 1995.
Where is ASBIS headquartered?ASBIS is headquartered in Cyprus.
How many employees does ASBIS have?As of today, ASBIS has over 2K employees.
Who is the CEO of ASBIS?ASBIS's CEO is Siarhei Kostevitch.
Is ASBIS publicly listed?Yes, ASBIS is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of ASBIS?ASBIS trades under ASB ticker.
When did ASBIS go public?ASBIS went public in 2007.
Who are competitors of ASBIS?ASBIS main competitors include Distribution Solutions Group, MCJ, HTC, Fenda Technology, Aamal Company, Guangzhou Pearl River, Global Industrial, Sun Corp., Telling Telecommunication, Primax Electronics.
What is the current market cap of ASBIS?ASBIS's current market cap is $1B.
What is the current revenue of ASBIS?ASBIS's last 12 months revenue is $4B.
What is the current revenue growth of ASBIS?ASBIS revenue growth (NTM/LTM) is 18%.
What is the current EV/Revenue multiple of ASBIS?Current revenue multiple of ASBIS is 0.3x.
What is the current EBITDA of ASBIS?ASBIS's last 12 months EBITDA is $139M.
What is ASBIS's EBITDA margin?ASBIS's last 12 months EBITDA margin is 3%.
What is the current EV/EBITDA multiple of ASBIS?Current EBITDA multiple of ASBIS is 9.8x.
What is the current FCF of ASBIS?ASBIS's last 12 months FCF is $82M.
What is ASBIS's FCF margin?ASBIS's last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of ASBIS?Current FCF multiple of ASBIS is 16.6x.
How many companies ASBIS has acquired to date?As of June 2026, ASBIS has acquired 2 companies.
What was the largest acquisition by ASBIS?$574M acquisition of Avectis on 15th July 2019 was the largest M&A ASBIS has done to date.
What companies ASBIS acquired?ASBIS acquired Avectis and CPT Praha.
In how many companies ASBIS has invested to date?As of June 2026, ASBIS has invested in 2 companies.
What was the last ASBIS investment?On 9th November 2022 ASBIS invested in ProMed BioSciences, participating in a $800K Strategic investment round at $5M valuation.
In what companies ASBIS invested in?ASBIS invested in EMBIO Diagnostics and ProMed BioSciences.

See public comps similar to ASBIS

Lists including ASBIS

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial